A Polygenic Response Predictor Indicates Survival Benefit of Beta-Blockade in Heart Failure Patients

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.317
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Acute Endothelin a Receptor Blockade in Heart Failure Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Haemodynamic Effects of Beta-Adrenergic Blockade in Hyperthyroid Patients With and Without Heart Failure.

BMJ
1977English

Is a Polygenic Predictor of Antidepressant Response a Possibility?

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2017English

Survival Benefit of Implantable Cardioverter-Defibrillators in Left Ventricular Assist Device–Supported Heart Failure Patients

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2012English

Mortality Benefit of Beta Blockade in Patients With Acute Coronary Syndromes Undergoing Coronary Intervention:

Journal of Interventional Cardiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2003English

Beta-Blocker Use at Discharge in Patients Hospitalized for Heart Failure Is Associated With Improved Survival

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Palliative Outpatient Inotrope in End Stage Heart Failure Patients Is Safe With Moderate Survival Benefit: A Single Center Retrospective Study

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

-Adrenergic Receptor Blockade in Chronic Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients With Chronic Stable Heart Failure

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy